Prognostic Significance of Cardiac Injury in COVID-19 Patients with and Without Coronary Artery Disease
Overview
Authors
Affiliations
Objective: COVID-19 is a disease with high mortality, and risk factors for worse clinical outcome have not been well-defined yet. The aim of this study is to delineate the prognostic importance of presence of concomitant cardiac injury on admission in patients with COVID-19.
Methods: For this multi-center retrospective study, data of consecutive patients who were treated for COVID-19 between 20 March and 20 April 2020 were collected. Clinical characteristics, laboratory findings and outcomes data were obtained from electronic medical records. In-hospital clinical outcome was compared between patients with and without cardiac injury.
Results: A total of 607 hospitalized patients with COVID-19 were included in the study; the median age was 62.5 ± 14.3 years, and 334 (55%) were male. Cardiac injury was detected in 150 (24.7%) of patients included in the study. Mortality rate was higher in patients with cardiac injury (42% vs. 8%; P < 0.01). The frequency of patients who required ICU (72% vs. 19%), who developed acute kidney injury (14% vs. 1%) and acute respiratory distress syndrome (71%vs. 18%) were also higher in patients with cardiac injury. In multivariate analysis, age, coronary artery disease (CAD), elevated CRP levels, and presence of cardiac injury [odds ratio (OR) 10.58, 95% confidence interval (CI) 2.42-46.27; P < 0.001) were found to be independent predictors of mortality. In subgroup analysis, including patients free of history of CAD, presence of cardiac injury on admission also predicted mortality (OR 2.52, 95% CI 1.17-5.45; P = 0.018).
Conclusion: Cardiac injury on admission is associated with worse clinical outcome and higher mortality risk in COVID-19 patients including patients free of previous CAD diagnosis.
Hu F, Zang M, Zheng L, Chen W, Guo J, Du Z Rev Cardiovasc Med. 2024; 23(11):362.
PMID: 39076199 PMC: 11269060. DOI: 10.31083/j.rcm2311362.
Mechanisms influencing the high prevalence of COVID-19 in diabetics: A systematic review.
Jain R, Mathew D Med Res Arch. 2024; 11(10).
PMID: 38933091 PMC: 11198970. DOI: 10.18103/mra.v11i10.4540.
The Aftermath of COVID-19: Exploring the Long-Term Effects on Organ Systems.
Golzardi M, Hromic-Jahjefendic A, Sutkovic J, Aydin O, Unal-Aydin P, Becirevic T Biomedicines. 2024; 12(4).
PMID: 38672267 PMC: 11048001. DOI: 10.3390/biomedicines12040913.
Sljivo A, Brigic L, Abdulkhaliq A, Dadic I, Reiter L, Sirucic I Mater Sociomed. 2024; 35(4):290-294.
PMID: 38380286 PMC: 10875953. DOI: 10.5455/msm.2023.35.290-294.
Wang S, Zhu R, Zhang C, Guo Y, Lv M, Zhang C PLoS One. 2023; 18(10):e0292021.
PMID: 37815980 PMC: 10564240. DOI: 10.1371/journal.pone.0292021.